Template:Main Page News: Difference between revisions
From Embryology
mNo edit summary |
mNo edit summary |
||
Line 1: | Line 1: | ||
{| width=700px| | {| width=700px| | ||
|-bgcolor="CEDFF2" | |-bgcolor="CEDFF2" | ||
| <span style="font-size:150%">'''News - | | <span style="font-size:150%">'''News - CRISPR Gene Editing'''</span> | ||
|-bgcolor="F5FAFF" | |-bgcolor="F5FAFF" | ||
| valign=top| [[File: | | valign=top| [[File:CRISPR Cas9 interaction with target DNA.jpg|250px|right|alt=CRISPR Cas9 interaction with target DNA|link=]] | ||
It has been reported (but not confirmed by publication) that USA scientists have [https://www.technologyreview.com/s/608350/first-human-embryos-edited-in-us/amp/ gene-edited embryos using CRISPR] | |||
:'''Links:''' [[ | This follows on from an earlier 2015 published work ([https://www.ncbi.nlm.nih.gov/pubmed/25894090 PMID 25894090]) from China using the same technique [http://www.nature.com/news/chinese-scientists-genetically-modify-human-embryos-1.17378 see Nature 22 April 2015] and a more recent 2017 paper ([https://www.ncbi.nlm.nih.gov/pubmed/?term=28251317 PMID 28251317]). | ||
'''About CRISPR''' | |||
The CRISPR/Cas9-mediated gene editing system was derived from the adaptive immune system evolved in bacteria to defend against invading plasmids and viruses. | |||
:'''Links:''' [[Molecular_Development_-_Genetics#CRISPR|CRISPR]] | [[Molecular_Development_-_Genetics|Genetics]] | |||
|- | |- | ||
| | | | ||
:[[Template_talk:Main_Page_News|'''Older News Articles''']] - [[Template_talk:Main_Page_News#September|Kyoto eBook]] | [[Template_talk:Main_Page_News#August|Dolly's sisters live on!]] | [[Template_talk:Main_Page_News#June|Thalidomide in Zebrafish]] | [[Template_talk:Main_Page_News#March|Human pancreas stem cells]] | [[Template_talk:Main_Page_News#January|Oral contraceptive no risk of major birth defects]] | [[Template_talk:Main_Page_News#September|Maternal Malaria Neurovascular Development Effects]] | [[Template_talk:Main_Page_News#June|Oocyte/Spermatozoa fate decision]] [[Template_talk:Main_Page_News#April|Rubella eliminated in the Americas]] | [[Template_talk:Main_Page_News#February|Three-person embryos]] | :[[Template_talk:Main_Page_News|'''Older News Articles''']] - [[Template_talk:Main_Page_News#February Gestational Diabetes]] | [[Template_talk:Main_Page_News#September|Kyoto eBook]] | [[Template_talk:Main_Page_News#August|Dolly's sisters live on!]] | [[Template_talk:Main_Page_News#June|Thalidomide in Zebrafish]] | [[Template_talk:Main_Page_News#March|Human pancreas stem cells]] | [[Template_talk:Main_Page_News#January|Oral contraceptive no risk of major birth defects]] | [[Template_talk:Main_Page_News#September|Maternal Malaria Neurovascular Development Effects]] | [[Template_talk:Main_Page_News#June|Oocyte/Spermatozoa fate decision]] [[Template_talk:Main_Page_News#April|Rubella eliminated in the Americas]] | [[Template_talk:Main_Page_News#February|Three-person embryos]] | ||
|} | |} |
Revision as of 11:35, 28 July 2017
News - CRISPR Gene Editing |
It has been reported (but not confirmed by publication) that USA scientists have gene-edited embryos using CRISPR This follows on from an earlier 2015 published work (PMID 25894090) from China using the same technique see Nature 22 April 2015 and a more recent 2017 paper (PMID 28251317).
The CRISPR/Cas9-mediated gene editing system was derived from the adaptive immune system evolved in bacteria to defend against invading plasmids and viruses. |
|